pharmaceutical mock audit is an in-depth evaluation that replicates the investigative methodology, inquiry style, and rigor of official regulatory bodies. It acts as an independent audit of a manufacturing plant’s alignment with Good Manufacturing Practices (GMP), existing quality management systems, record requirements, and established regulatory expectations. Unlike standard internal audits, which typically focus on adherence to internal company policies and SOPs, a mock

This June 2026 notification signals a maturing pharmacovigilance framework. For stakeholders from large-scale manufacturers and CMOs to frontline healthcare providers, the message is clear: scientific justification is the only path to market survival. This article breaks down the ban and explores the strategic shifts necessary for industry compliance.